Simultaneous magnetic resonance angiography and perfusion with nuclear magnetic resonance fingerprinting

US10379189B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10379189-B2
Application numberUS-201414444737-A
CountryUS
Kind codeB2
Filing dateJul 28, 2014
Priority dateJul 28, 2014
Publication dateAug 13, 2019
Grant dateAug 13, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Embodiments associated with combined magnetic resonance angiography and perfusion (MRAP) and nuclear magnetic resonance (NMR) fingerprinting are described. One example apparatus repetitively and variably samples a (k, t, E) space associated with an object to acquire a set of NMR signals that are associated with different points in the (k, t, E) space. Sampling is performed with t and/or E varying in a non-constant way. The apparatus includes a signal logic that produces an NMR signal evolution from the NMR signals and a characterization logic that characterizes a resonant species in the object as a result of comparing acquired signals to reference signals. The apparatus includes an MRAP logic that simultaneously performs MR angiography and produces quantitative perfusion maps. A multi-factor MR bio-imaging panel is produced from a combination of the data provided by the MRAP and NMR fingerprinting. Diagnoses may be made from the multi-factor MR bio-imaging panel.

First claim

Opening claim text (preview).

What is claimed is: 1. An apparatus, comprising: a nuclear magnetic resonance (NMR) apparatus, comprising a computing device and a display, the computing device including a microprocessor configured to control the NMR apparatus and that is further configured to perform a combined magnetic resonance angiography and perfusion (MRAP)/magnetic resonance fingerprinting (MRF) (MRAP/MRF) excitation to acquire, via the microprocessor configured to perform simultaneous MRAP/MRF acquisition, a first set of data and a second set of data simultaneously, wherein the first set of data repetitively and variably samples a (k, t, E) space associated with an object to acquire a set of NMR signals, where members of the first set of data are associated with different points in the (k, t, E) space, where k is data acquired by the NMR apparatus, t is time, and E includes at least one of, T 1 , T 2 , and one other parameter, T 1 being spin-lattice relaxation, and T 2 being spin-spin relaxation, and where one or more of, t and E, vary non-linearly, and wherein the second set of data includes magnetic resonance (MR) angiographic data and perfusion data; the microprocessor further configured to communicate with the NMR apparatus and is programmed to: acquire the first set of data and the second set of data, simultaneously, from the object using the MRAP/MRF acquisition; produce one or more quantitative relaxation parameter, a magnetic resonance angiogram (MRA), and a quantitative perfusion measurement associated with the object, wherein the one or more quantitative relaxation parameter is produced based on the first set of data, and wherein the MRA and the quantitative perfusion measurement are produced based on the second set of data; produce information concerning vascularization associated with the object based, at least in part, on the one or more quantitative relaxation parameter, the MRA, and the quantitative perfusion measurement; and display the information concerning vascularization associated with the object on the display. 2. The apparatus of claim 1 , controlled by the microprocessor, wherein the NMR apparatus is configured to generate the first data set by applying RF energy to the object in a series of variable sequence blocks to elicit one or more resonant species in the object to simultaneously produce the set of NMR signals, and acquire the set of NMR signals from the object in response to the RF energy to produce the (k, t, E) space. 3. The apparatus of claim 2 further comprising an auto-injector, controlled by the microprocessor, where the first set of data and the second set of data are produced after the auto-injector administers a contrast agent to the object. 4. The apparatus of claim 3 , controlled by the microprocessor, where the administration of the contrast agent is a single administration. 5. The apparatus of claim 1 , wherein the quantitative relaxation parameter includes a T 1 relaxation associated with the object, a T 2 relaxation associated with the object, a diffusion coefficient associated with the object, a spin density associated with the object, a proton density associated with the object, a magnetic field to which the object was exposed, or a gradient field to which the object was exposed. 6. The apparatus of claim 1 , wherein the object is a patient and wherein the microprocessor is further configured to diagnose a disease, comprising peripheral arterial disease, in the patient based, at least in part, on the one or more quantitative relaxation parameter, the MRA, and the quantitative perfusion measurement. 7. The apparatus of claim 1 , wherein the object is a patient and wherein the microprocessor is further configured to diagnose a severity of a disease, comprising peripheral arterial disease, in the patient based, at least in part, on the one or more quantitative relaxation parameter, the MRA, and the quantitative perfusion measurement. 8. The apparatus of claim 1 , wherein the microprocessor is further configured to identify the efficacy of a treatment to the object based, at least in part, on the one or more quantitative relaxation parameter, the MRA, and the quantitative perfusion measurement. 9. The apparatus of claim 1 , wherein the microprocessor is further configured to produce an MR image of the object based, at least in part, on the first set of data. 10. The apparatus of claim 1 , wherein the microprocessor is further configured to produce an MR image of the object based, at least in part, on the second set of data. 11. The apparatus of claim 1 , wherein the microprocessor is further configured to produce an MR image of the object based, at least in part, on the first set of data and the second set of data. 12. The apparatus of claim 1 , wherein displaying the information concerning vascularization associated with the object further comprises producing an image concerning vascularization associated with the object based, at least in part, on the one or more quantitative relaxation parameter, the MRA, and the quantitative perfusion measurement. 13. The apparatus of claim 1 , wherein the information concerning vascularization associated with the object is associated with an organ. 14. The apparatus of claim 1 , wherein the information concerning vascularization associated with the object is associated with a tumor. 15. The apparatus of claim 1 , wherein the microprocessor is further configured to acquire the first set of data and the second set of data using a single MRAP/MRF acquisition.

Assignees

Inventors

Classifications

  • involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title

  • Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369) · CPC title

  • Perfusion imaging · CPC title

  • adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography · CPC title

  • Relaxometry, i.e. quantification of relaxation times or spin density (G01R33/50 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10379189B2 cover?
Embodiments associated with combined magnetic resonance angiography and perfusion (MRAP) and nuclear magnetic resonance (NMR) fingerprinting are described. One example apparatus repetitively and variably samples a (k, t, E) space associated with an object to acquire a set of NMR signals that are associated with different points in the (k, t, E) space. Sampling is performed with t and/or E varyi…
Who is the assignee on this patent?
Univ Case Western Reserve
What technology area does this patent fall under?
Primary CPC classification G01R33/5635. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).